Accéder directement au contenu

Tabassome SIMON

5
Documents
Identifiants chercheurs

Présentation

Publications

"Risk Assessment"

Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel

Dominick Angiolillo , Davide Capodanno , Nicolas Danchin , Tabassome Simon , Thomas Bergmeijer
JACC: Cardiovascular Interventions, 2020, 13 (5), pp.606-617. ⟨10.1016/j.jcin.2020.01.226⟩
Article dans une revue hal-03030882v1
Image document

High-intensity lipid-lowering regimens in patients with stable coronary artery disease: the intriguing question of all-cause mortality

Nicolas Danchin , Tabassome Simon
European Heart Journal - Cardiovascular Pharmacotherapy, 2020, 6 (4), pp.328 - 330. ⟨10.1093/ehjcvp/pvz049⟩
Article dans une revue hal-03028620v1

Outcome associated with prescription of cardiac rehabilitation according to predicted risk after acute myocardial infarction: Insights from the FAST-MI registries

Hanna Debiec , Claire Dossier , Eric Letouzé , Christopher Gillies , Marina Vivarelli
Archives of cardiovascular diseases, 2019, 112 (8-9), pp.459-468. ⟨10.1016/j.acvd.2019.04.002⟩
Article dans une revue hal-03026552v1

Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points—Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)

Thomas Bergmeijer , Jean-Luc Reny , Ruth Pakyz , Li Gong , Joshua Lewis
American Heart Journal, 2018, 198, pp.152-159. ⟨10.1016/j.ahj.2017.12.010⟩
Article dans une revue hal-03025815v1

Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: The 2005 French FAST-MI study.

Marion Pouche , Jean Ruidavets , Jean Ferrières , Marie-Christine Iliou , Hervé Douard
Archives of cardiovascular diseases, 2016, 109 (3), pp.178-87. ⟨10.1016/j.acvd.2015.09.009⟩
Article dans une revue hal-01441551v1